Shattuck Labs (STTK) Total Liabilities (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Total Liabilities of $6.3 million for Q1 2026, down 34.39% year-over-year from $9.6 million in Q1 2025, and down 27.21% quarter-over-quarter from $8.6 million in Q4 2025.
Shattuck Labs (STTK) Total Liabilities (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Total Liabilities for 8 consecutive years, with $6.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 34.39% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.3 million (down 34.39% YoY), while the FY2025 annual figure was $8.6 million, down 24.4% from the prior year.
- Total Liabilities declined to $6.3 million in Q1 2026 per STTK's latest filing, from $8.6 million in the prior quarter.
- Across five years, Total Liabilities topped out at $29.2 million in Q4 2022 and bottomed at $6.3 million in Q1 2026.
- Historically, Total Liabilities has averaged $16.1 million across 5 years, with a median of $16.8 million in 2023.
- Annual changes were most pronounced in 2022 — Total Liabilities gained 8.84% — and 2025, when it tumbled 59.15%.
- Shattuck Labs' Total Liabilities stood at $29.2 million in 2022, then slumped by 49.06% to $14.9 million in 2023, then declined by 23.12% to $11.4 million in 2024, then retreated by 24.4% to $8.6 million in 2025, then declined by 27.21% to $6.3 million in 2026.
- Business Quant data shows STTK's Total Liabilities at $6.3 million in Q1 2026, $8.6 million in Q4 2025, and $7.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 9.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.53 Mn |
| Mar 31, 2026 | 6.29 Mn |
| Dec 31, 2025 | 8.64 Mn |
| Sep 30, 2025 | 7.09 Mn |
| Jun 30, 2025 | 7.35 Mn |
| Mar 31, 2025 | 9.58 Mn |
| Dec 31, 2024 | 11.42 Mn |
| Sep 30, 2024 | 15.14 Mn |
| Jun 30, 2024 | 18.00 Mn |
| Mar 31, 2024 | 17.52 Mn |
| Dec 31, 2023 | 14.86 Mn |
| Sep 30, 2023 | 17.67 Mn |
| Jun 30, 2023 | 16.81 Mn |
| Mar 31, 2023 | 20.02 Mn |
| Dec 31, 2022 | 29.17 Mn |
| Sep 30, 2022 | 23.53 Mn |
| Jun 30, 2022 | 28.81 Mn |
| Mar 31, 2022 | 21.55 Mn |
| Dec 31, 2021 | 26.80 Mn |
| Sep 30, 2021 | 49.40 Mn |